Multicenter Clinical Trial, Phase III, Controlled, Open, Parallel Group, Randomized, Comparing the Fixed Dose Combination of Diphenhydramine + Dropropizine + Pseudoephedrine and the Combined Use of Dropropizine and Fixed Dose Combination of Pseudoephedrine Hydrochloride + Brompheniramine Maleate Used Orally for Evaluation of Efficacy and Safety in Control Cough and the Relief of Nasal Symptoms in Children 2 to 12 Years Old, Suffering From Non-productive Cough and Acute Rhinitis.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Brompheniramine/pseudoephedrine; Diphenhydramine/dropropizine/pseudoephedrine; Dropropizine
- Indications Cough; Rhinitis
- Focus Therapeutic Use
Most Recent Events
- 19 Oct 2016 Biomarkers information updated
- 12 Jul 2011 Planned End Date added to 1 Apr 2012 as reported by ClinicalTrials.gov.
- 12 Jul 2011 Planned initiation date added to 1 Oct 2011 as reported by ClinicalTrials.gov.